The Importance of a Multidisciplinary Approach to Lung Cancer Patients in the Era of Immuno-Oncology - A Case Report of Multi-Organ Toxicity with Checkpoint Inhibitor Treatment

被引：0
|
作者：
Weintraub, S. [1 ]
Newman, J. [1 ]
Thomas, R. [1 ]
Seetharamu, N. [1 ]
机构：
[1] North Shore Univ Hosp, Internal Med, Manhasset, NY USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3342
引用
收藏
页数：1
相关论文
共 39 条
  • [1] Association of retinoblastoma function with response to immuno-oncology treatment in patients with small cell lung cancer
    Balli, David
    Wang, Xuya
    Rizvi, Naiyer A.
    Chan, Timothy A.
    Dowlati, Afshin
    Doshi, Parul
    Chang, Han
    CANCER RESEARCH, 2020, 80 (16)
  • [2] What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?
    Reck, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 28 - 34
  • [3] Multidisciplinary approach for acute MI complicated by ventricular tachycardia, stent thrombosis, and multi-organ failure: A case report
    Dutta, Ujjwal P.
    Bhatt, Jugal Hiren
    Nagori, Irfan
    Kagathara, Nency
    Zalavadiya, Rushit
    Sapkota, Dilip
    CLINICAL CASE REPORTS, 2024, 12 (02):
  • [4] Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients
    Robert S. Seitz
    Michael E. Hurwitz
    Tyler J. Nielsen
    Daniel B. Bailey
    Matthew G. Varga
    Brian Z. Ring
    Carrie F. Metts
    Brock L. Schweitzer
    Kimberly McGregor
    Douglas T. Ross
    Journal of Translational Medicine, 20
  • [5] Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients
    Seitz, Robert S.
    Hurwitz, Michael E.
    Nielsen, Tyler J.
    Bailey, Daniel B.
    Varga, Matthew G.
    Ring, Brian Z.
    Metts, Carrie F.
    Schweitzer, Brock L.
    McGregor, Kimberly
    Ross, Douglas T.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [6] Transforming Lung Cancer Management: A Promising Case Study of Immune Checkpoint Inhibitor Success Following a Multidisciplinary Approach
    Nishimura, Tadashi
    Fujimoto, Hajime
    Fujiwara, Takumi
    Okano, Tomohito
    Yasuma, Taro
    Gabazza, Esteban C.
    Ibata, Hidenori
    Kobayashi, Tetsu
    DIAGNOSTICS, 2024, 14 (19)
  • [7] Diffusion of innovation in oncology: A case study of immuno-oncology (IO) adoption for advanced non-small lung cancer (aNSCLC) patients across practices in the US
    Bennette, Caroline Savage
    Torres, Aracelis Z.
    Tucker, Melisa
    Khozin, Sean
    Abernethy, Amy Pickar
    Brown, Nicholas R.
    Meropol, Neal J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] A REPORT OF REFRACTORY ATEZOLIZUMAB INDUCED MULTI-ORGAN FAILURE IN THE TREATMENT OF STAGE IV SMALL-CELL LUNG CANCER
    Goldenberg, Lucas
    Heydari-Kamjani, Milad
    Rios, Javier
    Pendlebury, David
    Sakr, Lewjain
    CHEST, 2023, 164 (04) : 3348A - 3349A
  • [9] Real-world immuno-oncology treatment patterns and outcomes in US patients with metastatic non-small-cell lung cancer.
    Bruno, Amanda
    Bell, Kelly
    Stafkey-Mailey, Dana
    Murty, Sharanya
    Ballas, Marc S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] 3D laparoscopic treatment of bladder cancer with pelvic multi-organ invasion: a case report and literature review
    Chen, Zheng
    Deng, Kaifeng
    Sun, Luping
    Qu, Lijun
    Chao, Xinhui
    Rao, Jingmin
    Hong, Caimmei
    Zhuo, Yumin
    Lin, Zhichao
    Lai, Caiyong
    FRONTIERS IN ONCOLOGY, 2023, 13
1234